Challenges in Management of Pediatric Chronic Myeloid Leukemia (pCML) in the Low-Middle Income Countries (LMICs): Insights from an International CML Foundation (iCMLf) Multi-National Survey.

Pediatric CML low-middle income countries survey

Journal

Pediatric hematology and oncology
ISSN: 1521-0669
Titre abrégé: Pediatr Hematol Oncol
Pays: England
ID NLM: 8700164

Informations de publication

Date de publication:
16 Jan 2024
Historique:
medline: 17 1 2024
pubmed: 17 1 2024
entrez: 17 1 2024
Statut: aheadofprint

Résumé

Despite being a rare disease, high-income countries (HICs) have formulated guidelines for management of pediatric CML (pCML). We conducted a survey amongst 24 physicians from 22 Low-Middle Income Countries (LMICs) to gather information regarding their practice and experience in treating children with pCML. Rarity of pCML, lack of adequate expertise, and setting-adapted guidelines along with limitations in diagnostic infrastructure as well as challenges in accessing tyrosine kinase inhibitors (TKIs) were identified as major barriers in optimum management of patients. For the first time in literature, our findings provide valuable insights into the multifaceted challenges faced in managing pCML in LMICs.

Identifiants

pubmed: 38229452
doi: 10.1080/08880018.2023.2301404
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-6

Auteurs

Nirmalya Roy Moulik (N)

Pediatric Oncology, Tata Memorial Hospital, Mumbai, India.

Arlene Harriss-Buchan (A)

International CML foundation, UK.

Giuseppe Saglio (G)

Clinical and Biological Sciences, University of Turin, Turin, Italy.

Meinolf Suttorp (M)

Pediatric Hemato-Oncology, Medical Faculty, Technical University of Dresden, Dresden, Germany.

Classifications MeSH